Investors now weigh whether OpenAI and Anthropic can top the record SpaceX debut once the two AI labs finally reach public markets.Investors now weigh whether OpenAI and Anthropic can top the record SpaceX debut once the two AI labs finally reach public markets.

OpenAI And Anthropic Could Turn SpaceX’s Record IPO Into The Warm-Up

2026/06/13 03:09
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

SpaceX completed a record stock market debut this week, leaving investors to weigh whether artificial intelligence labs OpenAI and Anthropic can outshine it once they list.

Key Points:

SpaceX Sets $1.77 Trillion Mark

SpaceX priced its offering at a fixed $135 a share for 555.6 million shares, according to market reports, and began trading on the Nasdaq under the ticker SPCX. The roughly $75 billion raise values the company near $1.77 trillion, well above the $780 billion that some analysts had called fair. That figure ranks as the largest U.S. listing on record.

OpenAI and Anthropic took the opposite path on disclosure, each submitting a confidential draft registration in early June that signals intent without locking in a date, ticker or price. Anthropic announced its draft on Jun. 1, days after closing a $65 billion round at a $965 billion valuation, with OpenAI following a week later.

Also Read: Jeff Bezos Says AI May Not Kill Jobs As Prometheus Raises $12B

Pure-Play AI Lures Demand

The case for the labs rests on what investors cannot yet buy.

For years, money managers reached AI through proxies like chipmakers and cloud platforms, and a direct stake in a frontier lab would unlock demand from the roughly $8 trillion parked in U.S. money market funds. Anthropic reported a $47 billion revenue run rate in May, while OpenAI carried an $852 billion valuation after closing a $122 billion funding round in March.

Supporters argue these are real businesses, not hollow promises, since subscriptions and enterprise contracts already produce steady cash. Revenue, not promise, is the difference.

Supply Raises Red Flags

Skeptics see a flood of stock rather than a windfall. Capital Economics estimates that wider free floats could push about $750 billion in fresh equity onto the market, and it found that issuance surges have tracked the late stages of past booms. Only 4% to 5% trades at launch, capping early index weight.

Commentators have also cautioned](https://www.bloomberg.com/opinion/articles/2026-06-12/spacex-anthropic-openai-ipos-are-a-red-flag-for-stock-market-s-future) that absorbing three giant listings in quick succession is rare for any market. SpaceX adds a wrinkle, since it ranks as AI-adjacent rather than a pure lab, with rockets, satellites and Starlink driving most of its $18.7 billion in 2025 revenue and artificial intelligence arriving only through its xAI purchase.

Recent history shows how strong the pull has been. Cerebras, an AI chipmaker, opened about 89% above its offer price in its May debut. That reception set the tone for the listings now lined up behind it, in what could become a record year for U.S. IPOs, with the three deals alone capable of drawing about $200 billion.

Read Next: Bitget Clears Argentina Regulator, Adding Another Latin America Market

Market Opportunity
Gensyn Logo
Gensyn Price(AI)
$0.02686
$0.02686$0.02686
+0.48%
USD
Gensyn (AI) Live Price Chart

Predict & Trade to Win Rewards

Predict & Trade to Win RewardsPredict & Trade to Win Rewards

Guaranteed rewards with $500,000 prize pool

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

RealStocks Now Live

RealStocks Now LiveRealStocks Now Live

Trade real U.S. stock via regulated brokerage